This inventor holds 1 USPTO granted patent and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2023
Title: Anne Gigout - Innovator in Regenerative Medicine
Introduction
Anne Gigout is a notable inventor based in Darmstadt, Germany. She is currently associated with Merck Patent GmbH, where she focuses on advancements in regenerative medicine. Despite having no granted patents to her name, her contributions to the field are significant through her latest patent applications.
Latest Patent Applications
Anne Gigout has been involved in several innovative projects aimed at addressing cartilage disorders. One of her latest patent applications is titled "Use of the GDF-5 Mutant for the Treatment of Pain and Cartilage Destruction." This invention is directed towards utilizing the GDF-5 mutant with an amino acid exchange R399E for treating cartilage defects and pain, along with a pharmacological composition of the GDF-5 mutant. Another significant application is "FGF-18 in Graft Transplantation and Tissue Engineering Procedures." This invention provides a new method related to regenerative medicine for treating cartilage disorders, particularly osteoarthritis and cartilage injury. It focuses on an FGF-18 compound for use in tissue engineering and graft procedures, such as osteochondral or cartilage transplantation or autologous chondrocyte implantation (ACI).
Conclusion
Anne Gigout is making strides in the field of regenerative medicine through her innovative patent applications. Her work holds promise for future advancements in treating cartilage-related issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile